
Rexoby Pharmaceutical Private Limited
About Rexoby Pharmaceutical Private Limited
Data last updated:
Rexoby Pharmaceutical Private Limited is a private limited company based in Noida, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24100UP2020PTC134664. Its GSTIN is 09AAKCR4465R2ZC (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gita and Sachin Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bh – 199 Sector – 70 Noida Gautam Buddha Nagar, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.89 Lakh, a decline of 68% compared to the previous year. For the same year it recorded a net loss of ₹3.05 Lakh (net margin -78.4%) and EBITDA of -₹3.04 Lakh (EBITDA margin -78.2%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years.
Rexoby Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-02-0014904).
Company details
Recognitions & Rankings of Rexoby Pharmaceutical
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-02-0014904
Contact details
Rexoby Pharmaceutical Private Limited's registered office is in Noida, Uttar Pradesh.
- Registered AddressBh – 199 Sector – 70 Noida Gautam Buddha Nagar, Uttar Pradesh, India – 201301
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rexoby Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rexoby Pharmaceutical Private Limited, buy the company report.
Financials of Rexoby Pharmaceutical Private Limited
FY 2025 filings availableRexoby Pharmaceutical Private Limited reported revenue of ₹3.89 Lakh (down 68% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 68% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA fell 470% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹3.04 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹3.05 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -78.2% | |||
| Net Profit Margin | -78.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Rexoby Pharmaceutical Private Limited, buy the company report.
Board of directors of Rexoby Pharmaceutical Private Limited
Rexoby Pharmaceutical has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gita Also directs: Endeavour Safety Solutions Private Limited | Director | 05 Jul 2023 | 3 Years 4 Months | Current |
| Sachin Yadav | Director | 15 Sep 2020 | 6 Years 2 Months | Current |
Peer comparison
Rexoby Pharmaceutical Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cma Genesis Remedies Private Limited | ₹3.98 Lakh (FY 2016) | -1.0% | Mumbai, Maharashtra, India | |||
| Savicure Remedies Private Limited | ₹3.94 Lakh (FY 2020) | New Delhi, Delhi, India | ||||
| Rexoby Pharmaceutical Private Limitedthis company | ₹3.89 Lakh (FY 2024) | -₹3.05 Lakh | -78.4% | -68.0% | Noida, Uttar Pradesh, India | |
| Pdanil Healthcare Private Limited | ₹3.88 Lakh (FY 2024) | -39.0% | Agra, Uttar Pradesh, India | |||
| Phyto Medicines Ltd. | ₹3.84 Lakh (FY 2025) | 151.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Rexoby Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rexoby Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rexoby Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rexoby Pharmaceutical has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCR4465R2ZC | Uttar Pradesh | Active | 13 May 2022 |
To see the full GST registrations and return filing status of Rexoby Pharmaceutical Private Limited, buy the company report.
Recent activity
Rexoby Pharmaceutical Private Limited has 6 board changes on record since 2020: 4 appointments and 2 cessations. The latest: Gita was appointed as Director on 05 Jul 2023.
Frequently asked questions
Rexoby Pharmaceutical is an active private limited company based in Noida, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 September 2020 (6+ years old) and is registered under CIN U24100UP2020PTC134664.
Rexoby Pharmaceutical has 2 current directors:
- Gita - Director
- Sachin Yadav - Director
The latest financial statements of Rexoby Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Rexoby Pharmaceutical is 09AAKCR4465R2ZC, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Rexoby Pharmaceutical is U24100UP2020PTC134664. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rexoby Pharmaceutical was incorporated on 15 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Rexoby Pharmaceutical by revenue are Cma Genesis Remedies Private Limited, Savicure Remedies Private Limited, Pdanil Healthcare Private Limited, Phyto Medicines Ltd, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Gita was appointed as Director on 05 Jul 2023. Shree Nivas was appointed as Director on 05 Oct 2022. Kumari Simpal ceased to be Director on 18 May 2022. Rexoby Pharmaceutical has 6 board changes on record in total.
Yes, Rexoby Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Rexoby Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-02-0014904).
The registered office of Rexoby Pharmaceutical is at Bh – 199 Sector – 70 Noida Gautam Buddha Nagar, Uttar Pradesh, India – 201301.

